Search

Your search keyword '"Li, Liao"' showing total 867 results

Search Constraints

Start Over You searched for: Author "Li, Liao" Remove constraint Author: "Li, Liao" Language undetermined Remove constraint Language: undetermined
867 results on '"Li, Liao"'

Search Results

1. What If Borrowers Were Informed about Credit Reporting? Two Natural Field Experiments

7. Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis

8. Gap-directed chemical lift-off lithographic nanoarchitectonics for arbitrary sub-micrometer patterning

12. Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus

15. Network Pharmacology and Transcriptomics Reveal the Mechanism of GuaLouQuMaiWan in Treatment of Type 2 Diabetes and Its Active Small Molecular Compound

18. Expressway Lane Change in Fog Environment by Dynamic Strategic Game

19. Influence of Supervisor Leadership Style and Conflict Handling on Subordinates: A Case Study of Taoyuan Police Department

20. Effectiveness of Chinese Native Culture Education for Improving Undergraduate Nursing Students’ Transcultural Self-Efficacy

24. Hypertension Exacerbates Severity and Outcomes of COVID-19 in Elderly Patients: A Retrospective Observational Study

26. Targeting of plasmodesmal proteins requires unconventional signals

27. Avoiding Peer Information and Its Effects on Charity Crowdfunding: A Field Experiment

29. Metal- and Pyrolysis-Free Ionic Covalent Organic Framework Nanosheet for Efficient Oxygen Evolution Reaction

32. Supplementary Figure 2 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

33. Supplementary Fig 3 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

34. Supplementary Fig 2 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

35. Supplementary Figure 1 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

36. Data from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

37. Supplementary Fig 5 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

38. Supplementary Figure 3 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

39. Supplementary Table 3 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

40. Supplementary Table 1 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

41. Supplementary Fig 6 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

42. Supplementary Figure 4 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

43. Supplementary Fig 4 from HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

44. Supplementary Table 2 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

45. Supplementary Table 1 from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

46. Data from EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer

47. Complete Remission of Widely Metastatic Human Epidermal Growth Factor Receptor 2–Amplified Pancreatic Adenocarcinoma After Precision Immune and Targeted Therapy With Description of Sequencing and Organoid Correlates

49. Data from Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

50. Economic evaluation of toripalimab combined with chemotherapy in the treatment of non-small cell lung cancer

Catalog

Books, media, physical & digital resources